Statements by ICMR Director General Dr. Balram Bhargav were made to urge citizens to continue to wear masks to slow the spread of the virus in the country. “That is why it is important to wear a mask and take precautions even if one was infected earlier,” Dr. Bhargava said during the Health Ministry briefing.
Previously, the ICMR had noted that such cases of virus reinfection were few, one in Ahmedabad and two in Mumbai.
“According to data from the World Health Organization (WHO), there are around 24 cases of reinfection in the world. The criteria to identify a case of reinfection is between 90 and 100 days. The WHO has not yet decided the number of days. However, we are taking a limit of approximately 100 days, “said Director General Dr. Balram Bhargava, ICMR.
On the solidarity trial implemented by the World Health Organization, Dr. Bhargava said: “The WHO solidarity trial is a 30-country trial in which India has participated and the interim results of this have been published in the website, which has not yet been peer reviewed. However, we found that these medications are not working as well as expected. “
Solidarity is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and its partners. It is one of the largest international randomized trials for COVID-19 treatments, enrolling nearly 12,000 patients at 500 hospital sites in more than 30 countries.
The Solidarity Trial is evaluating the effect of drugs on 3 important outcomes in COVID-19 patients: mortality, need for assisted ventilation, and length of hospital stay.
Furthermore, when informing the media about the coronavirus situation in the country, the Ministry of Health and Family Welfare reported that India has the highest number of recovered cases of Covid-19 in the world and ranks second in terms of number of tests carried out in any country. .
India’s COVID-19 cases per million inhabitants reported in the last 7 days amount to 310, while the global average is 315, said Rajesh Bhushan of the Health Ministry.
Maharashtra, Karnataka, Kerala, Tamil Nadu, Andhra Pradesh, West Bengal account for 64% of all active COVID-19 cases, it added.
On the subject of oxygen production capacity, Bhushan added that oxygen production capacity increased from 5,913 MT in April to 6,862 MT in September and will continue to increase to 7,191 MT at the end of October.
“2,65,046 oxygen beds, 7,71,36 ICU beds and 39,527 ventilation beds available in the country as of October 19,” the Ministry of Health said.
Meanwhile, India on Tuesday reported a single-day spike of 46,790 in new covid cases, the lowest single-day count in nearly three months. The total burden of cases increased to 75.97 lakh, while the death toll increased to 1.15 lakh. The number of active cases fell to less than 7.5 lakh, as recoveries continued to outpace the increase in new daily cases. In the last 24 hours, 69,720 patients were declared cured of covid, bringing total recoveries to 67.33 lakh.
The national recovery rate has risen to 88.63%, while the COVID-19 fatality rate stands at 1.52%.
In 24 hours, 587 covid-related deaths were reported. So far, 9.61 crore covid has been tested in India at 10.32 lakh on Monday.
There are 7,48,538 active cases of coronavirus infection in the country, which comprises 9.85% of all cases, according to the data.
.
